glp 1 agonist diarrhea and vomiting 🟣 Ozempic (Semaglutide): Common Side Effects: ➟ Ozempic is a When the Breakthrough Obesity G-Agonist

Retatrutide should be considered a second-line or specialized first-line agent for complex cases once it gains regulatory approval

Guidelines for treating Type 2 diabetes, like the same American Diabetes Associations (ADAs), generally recommend that patients receive metformin, and if necessary, the addition of other medication(s) like: A dipeptidyl peptidase-4 (DPP-4) inhibitor like Januvia, A Glucagon-like peptide-1 (GLP-1) receptor agonists receptor agonist like Ozempic, A sodium glucose co-transporter 2 (SGLT-2) inhibitor like Invokana, and / or A thiazolidinediones (TZD) like pioglitazone

In 2025, 36% of employers offered to cover GLP-1 drugs as a treatment for both obesity and diabetes, with about 55% covering diabetes alone

15.2.11 VIKING THERAPEUTICS 15.2.12 SUN PHARMACEUTICAL INDUSTRIES LTD

Questions remain about the safety of these drugs with regard to the risk of pancreatitis and the development of MTC in patients receiving liraglutide

Abstract Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health